Clinical Trial Update: Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

View source ↗

Summary

This NIAMS-sponsored clinical trial evaluating antibodies associated with cognitive dysfunction in systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED